VALOCTOCOGENE ROXAPARVOVEC (va lok TOK oh jeen rox a PAR voe vek) treats hemophilia A. It works by helping your body make factor VIII, a protein that helps your blood clot. This lowers the risk of bleeding.

ROCTAVIAN Lifestyle Interactions

  • Valoctocogene Roxaparvovec, Suspension for injection

    • Interaction: Alcohol
    • Severity: Major
    • Notes for Consumers: Do not drink alcohol for 1 year after receiving this medication. Drinking alcohol within 1 year after receiving this medication increases the risk of liver injury. Contact your care team right away if you experience right upper belly pain, loss of appetite, nausea, light-colored stool, dark yellow or brown urine, yellowing skin or eyes, or unusual weakness or fatigue.
    • Notes for Professionals: Advise patients to avoid alcohol-containing beverages for 1 year after treatment with valoctocogene roxaparvovec. Drinking alcohol with this medication increases the risk of hepatotoxicity.

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment. Drug information is sourced from GSDD (Gold Standard Drug Database ) provided by Elsevier.